Relevance of hypoxia in radiation oncology: pathophysiology, tumor biology and implications for treatment. | Canada Hyperbarics Skip to main content
Review The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (I 2013

Relevance of hypoxia in radiation oncology: pathophysiology, tumor biology and implications for treatment.

Busk M, Horsman MR — The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (I, 2013

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers conducted a review to explore the relevance of hypoxia in radiation oncology, covering its pathophysiology, tumour biology, and implications for treatment.

What They Found

The review found that tumour hypoxia dramatically lowers radiation sensitivity and reduces the effectiveness of chemotherapeutics, leading to treatment resistance and poor prognosis. Fortunately, clinical imaging and gene-expression technologies are now available to assess tumour hypoxia, allowing for the identification of suitable patients for hypoxia-targeting treatments and monitoring their efficacy.

Canadian Relevance

This study does not report any direct Canadian connection or involvement.

Study Limitations

A limitation of this study is that, as a review, it synthesizes existing literature rather than presenting new experimental data.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Review
Category Radiation Injury
Source Pubmed
PubMed ID 24045619
Year Published 2013
Journal The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (I
MeSH Terms Animals; Cell Hypoxia; Genetic Therapy; Humans; Hyperbaric Oxygenation; Molecular Imaging; Neoplasms; Oxygen; Positron-Emission Tomography; Radiotherapy, Image-Guided; Tumor Microenvironment

Cite This Study

Share

This study relates to Delayed Radiation Injury. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Radiation Injury

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 2, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology